Poor risk cytogenetics AML was more frequent in FLT3-WT samples (51%) than in FLT3-ITD samples(31%); FLT3 receptor TKD mutation was present in (2/16) FLT3-ITD and (4/67) FLT3-WT samples. This evidence concerns the gene FLT3 and acute myeloid leukemia.